Letrobol 2.5mg Tablet contains Letrozole, an aromatase inhibitor used in the treatment of hormone-dependent breast cancer in postmenopausal women. It works by reducing the amount of estrogen produced in the body, thereby slowing or reversing the growth of estrogen-sensitive tumors.

Letrobol is also prescribed to prevent the recurrence of breast cancer after initial treatment and, in some cases, as an adjunct therapy for fertility management under strict medical supervision.

Uses of Letrobol 2.5mg Tablet

• Treatment of hormone receptor-positive breast cancer in postmenopausal women

• Prevention of recurrence or metastasis of breast cancer

• Supportive therapy after surgery, radiation, or chemotherapy

• Occasionally used in female infertility treatment (off-label use) under medical guidance

How Letrobol Works

Letrozole belongs to a class of drugs called aromatase inhibitors. It blocks the enzyme aromatase, which is responsible for converting androgens into estrogens. By lowering estrogen levels, it limits the fuel for estrogen-dependent cancer cells, slowing their growth and spread within the body.

Dosage and Administration

• Route: Oral

• Typical Dose: One 2.5mg tablet daily or as directed by the oncologist

• Take with or without food, at the same time each day

• Do not stop treatment unless advised by your doctor

Side Effects

Common Side Effects:

• Hot flashes

• Fatigue or dizziness

• Headache

• Joint or bone pain

• Sweating and insomnia

Serious Side Effects:

• Severe bone thinning (osteoporosis)

• Shortness of breath or chest pain

• Swelling in legs or feet

• Vision changes or jaundice (rare)

Seek immediate medical attention if severe or persistent symptoms occur.

Precautions and Warnings

• For postmenopausal women only; not recommended during pregnancy or breastfeeding

• Avoid use in premenopausal women unless specifically prescribed

• Regular bone density and cholesterol checks are advised during treatment

• Use with caution in patients with osteoporosis or heart disease

• Store below 30°C, protected from moisture and sunlight

Key Highlights

• Highly effective aromatase inhibitor for breast cancer treatment

• Reduces estrogen production to control tumor growth

• Prevents recurrence and supports long-term cancer management

• Proven safety and efficacy in postmenopausal women

• Manufactured by Biovenus Healthcare Pvt. Ltd., ensuring pharmaceutical-grade quality